The peripheral blood (PB) of high-grade breast cancer (BC) patients (n = 12) was analyzed for the frequency of early-stage MDSC (eMDSC), identified, by flow cytometry as Lin-HLA-DR-CD33+CD11b+ [as described in (3)]. This evidence concerns the gene CD33 and breast cancer.